Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Dietmar Marder"'
Autor:
Sergio Mingo Barba, Adela Ademaj, Dietmar Marder, Oliver Riesterer, Marco Lattuada, Rudolf M. Füchslin, Alke Petri-Fink, Stephan Scheidegger
Publikováno v:
International Journal of Hyperthermia, Vol 41, Iss 1 (2024)
AbstractIntroduction Hyperthermia (HT) induces various cellular biological processes, such as repair impairment and direct HT cell killing. In this context, in-silico biophysical models that translate deviations in the treatment conditions into clini
Externí odkaz:
https://doaj.org/article/ce25e1db2ce54d5c87320b8b31311a0c
Autor:
Adela Ademaj, Emsad Puric, Dietmar Marder, Olaf Timm, Thomas Kern, Roger A. Hälg, Susanne Rogers, Oliver Riesterer
Publikováno v:
International Journal of Hyperthermia, Vol 40, Iss 1 (2023)
AbstractPurpose: Radiotherapy (RT) in combination with deep regional hyperthermia (HT) after transurethral removal of bladder tumor (TURBT) can be offered to elderly and frail patients with muscle-invasive bladder cancer (MIBC).Methods: In total, 21
Externí odkaz:
https://doaj.org/article/1950480afb7247bb99bb52c11fbda94a
Autor:
Oliver Riesterer, Adela Ademaj, Emsad Puric, Brigitte Eberle, Marcus Beck, Silvia Gomez, Dietmar Marder, Eva Oberacker, Susanne Rogers, Roger A. Hälg, Thomas Kern, Sonja Schwenne, Jürgen Stein, Emanuel Stutz, Olaf Timm, Sebastian Zschaeck, Mathias S. Weyland, Paraskevi D. Veltsista, Stephen Wyler, Peter Wust, Stephan Scheidegger, Stephan Bodis, Pirus Ghadjar
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 1078-1087 (2022)
Background Transurethral resection of bladder tumor (TUR-BT) followed by chemoradiation (CRT) is a valid treatment option for patients with muscle-invasive bladder cancer (MIBC). This study aimed to investigate the efficacy of a tetramodal approach w
Externí odkaz:
https://doaj.org/article/3124c2542f004dd49d96ffbea0bbc532
Autor:
Niloy R. Datta, Dietmar Marder, Sneha Datta, Andreas Meister, Emsad Puric, Emanuel Stutz, Susanne Rogers, Brigitte Eberle, Olaf Timm, Michal Staruch, Oliver Riesterer, Stephan Bodis
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 296-307 (2021)
Background Thermal dose in clinical hyperthermia reported as cumulative equivalent minutes (CEM) at 43 °C (CEM43) and its variants are based on direct thermal cytotoxicity assuming Arrhenius ‘break’ at 43 °C. An alternative method centered on t
Externí odkaz:
https://doaj.org/article/4da429f6d5394b438f36990d4e718de0
Autor:
Niloy Ranjan Datta, Emanuel Stutz, Emsad Puric, Brigitte Eberle, Andreas Meister, Dietmar Marder, Olaf Timm, Susanne Rogers, Stephen Wyler, Stephan Bodis
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Purpose: To present the outcomes of a pilot study with hyperthermia (HT) and radiotherapy (RT) in elderly patients of muscle-invasive bladder cancers (MIBC) unfit for surgery or chemoradiotherapy (CTRT).Methods: Sixteen elderly patients with unifocal
Externí odkaz:
https://doaj.org/article/12013e900df9407399390a49c9b82e43
Autor:
Niloy Ranjan Datta, Emsad Puric, Juerg Heüberger, Dietmar Marder, Nicoletta Lomax, Olaf Timm, Priska Memminger, Stephan Bodis
Publikováno v:
Swiss Medical Weekly, Vol 145, Iss 1718 (2015)
QUESTIONS UNDER STUDY: The aim of this retrospective analysis was to evaluate the safety and efficacy of local hyperthermia (HT) and reirradiation (ReRT) in the management of preirradiated locoregional recurrent breast cancers at Kantonsspital Aarau,
Externí odkaz:
https://doaj.org/article/d419982c78334964a43f99dab4fa46df
Autor:
Adela Ademaj, Emsad Puric, Olaf Timm, David Kurti, Dietmar Marder, Thomas Kern, Roger A. Hälg, Susanne Rogers, Oliver Riesterer
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1241
Volume 15
Issue 4
Pages: 1241
Hyperthermia (HT) in combination with radio(chemo)therapy (RCT) is a well-established cancer treatment strategy. This report analyses the quality of life (QoL), toxicity and survival outcomes in patients with different tumor entities who received HT
Autor:
Bernhard C. Pestalozzi, Alexander Siebenhüner, Oliver Riesterer, Stephan Bodis, Christoph Mamot, Dietmar Marder, Niloy R. Datta, Emsad Puric, O. Timm, J. Knuchel, S. Khan, Matthias Guckenberger, S. Rogers
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss, Pp 109-113 (2021)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Intensification of chemoradiation with hyperthermia was feasible in nine patients with LAPC. • Only one grade three toxicity was reported and two tumours became resectable. • The 24 months median OS and 100% 1 year OS are superior
Autor:
Dietmar Marder, Oliver Riesterer, Stephan Bodis, Olaf Timm, Susanne Rogers, Michal Staruch, Andreas Meister, Niloy R. Datta, Emsad Puric, Sneha Datta, Emanuel Stutz, Brigitte Eberle
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 296-307 (2021)
Datta, Niloy R; Marder, Dietmar; Datta, Sneha; Meister, Andreas; Puric, Emsad; Stutz, Emanuel; Rogers, Susanne; Eberle, Brigitte; Timm, Olaf; Staruch, Michal; Riesterer, Oliver; Bodis, Stephan (2021). Quantification of thermal dose in moderate clinical hyperthermia with radiotherapy: a relook using temperature-time area under the curve (AUC). International journal of hyperthermia, 38(1), pp. 296-307. Taylor & Francis 10.1080/02656736.2021.1875060
Datta, Niloy R; Marder, Dietmar; Datta, Sneha; Meister, Andreas; Puric, Emsad; Stutz, Emanuel; Rogers, Susanne; Eberle, Brigitte; Timm, Olaf; Staruch, Michal; Riesterer, Oliver; Bodis, Stephan (2021). Quantification of thermal dose in moderate clinical hyperthermia with radiotherapy: a relook using temperature-time area under the curve (AUC). International journal of hyperthermia, 38(1), pp. 296-307. Taylor & Francis 10.1080/02656736.2021.1875060
BACKGROUND Thermal dose in clinical hyperthermia reported as cumulative equivalent minutes (CEM) at 43 °C (CEM43) and its variants are based on direct thermal cytotoxicity assuming Arrhenius 'break' at 43 °C. An alternative method centered on the a
Autor:
Adela Ademaj, Danai P. Veltsista, Pirus Ghadjar, Dietmar Marder, Eva Oberacker, Oliver J. Ott, Peter Wust, Emsad Puric, Roger A. Hälg, Susanne Rogers, Stephan Bodis, Rainer Fietkau, Hans Crezee, Oliver Riesterer
Publikováno v:
Cancers
Cancers, Vol 14, Iss 625, p 625 (2022)
Cancers, Vol 14, Iss 625, p 625 (2022)
Simple Summary Hyperthermia (HT) is a promising therapeutic option for multiple cancer entities as it has the potential to increase the cytotoxicity of radiotherapy (RT) and chemotherapy (CT). Thermometric parameters of HT are considered to have pote